Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Bristol Cup Posters

Identifieur interne : 001577 ( Main/Exploration ); précédent : 001576; suivant : 001578

Bristol Cup Posters

Auteurs :

Source :

RBID : ISTEX:715C0A559B50A8FE9E76AFA8ACA0294D0F6F6707

English descriptors


Url:
DOI: 10.1111/j.1365-2133.2011.10277.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Bristol Cup Posters</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:715C0A559B50A8FE9E76AFA8ACA0294D0F6F6707</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1111/j.1365-2133.2011.10277.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-1TJ69CTG-F/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002385</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002385</idno>
<idno type="wicri:Area/Istex/Curation">002385</idno>
<idno type="wicri:Area/Istex/Checkpoint">000553</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000553</idno>
<idno type="wicri:Area/Main/Merge">001579</idno>
<idno type="wicri:Area/Main/Curation">001577</idno>
<idno type="wicri:Area/Main/Exploration">001577</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Bristol Cup Posters</title>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="sub">Abstracts for the British Association of Dermatologists 91st Annual Meeting, 5‐7 July 2011, London, UK</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint>
<biblScope unit="vol">165</biblScope>
<biblScope unit="issue">s1</biblScope>
<biblScope unit="page" from="20">20</biblScope>
<biblScope unit="page" to="62">62</biblScope>
<biblScope unit="page-count">43</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2011-07">2011-07</date>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Abnormality</term>
<term>Abscess</term>
<term>Acad</term>
<term>Acad dermatol</term>
<term>Acne</term>
<term>Acral</term>
<term>Acral lesions</term>
<term>Adalimumab</term>
<term>Adverse effects</term>
<term>Adverse events</term>
<term>Aetiology</term>
<term>Alitretinoin</term>
<term>Allergy</term>
<term>Alloknesis</term>
<term>Alopecia</term>
<term>Alopecia areata</term>
<term>Antibiotic</term>
<term>Aqueous cream</term>
<term>Arch dermatol</term>
<term>Atopic</term>
<term>Atopic dermatitis</term>
<term>Atypical</term>
<term>Aureus</term>
<term>Badbir</term>
<term>Baseline</term>
<term>Beacon group</term>
<term>Belfast</term>
<term>Bexarotene</term>
<term>Bexarotene therapy</term>
<term>Biliary</term>
<term>Biliary sepsis</term>
<term>Biologics</term>
<term>Biopsy</term>
<term>Biopsy tract</term>
<term>Bone mineral density</term>
<term>Breslow</term>
<term>Breslow depth</term>
<term>Briakinumab</term>
<term>Bristol</term>
<term>British association</term>
<term>Bullosa</term>
<term>Carcinoma</term>
<term>Cardiff</term>
<term>Case report</term>
<term>Case reports</term>
<term>Case series</term>
<term>Centre</term>
<term>Chemotherapy</term>
<term>Chronic biliary obstruction</term>
<term>Chronic plaque psoriasis</term>
<term>Ciclosporin</term>
<term>Clinic</term>
<term>Clinical examination</term>
<term>Clinical features</term>
<term>Clinical meeting</term>
<term>Clinical meetings</term>
<term>Clinical practice</term>
<term>Clinical response</term>
<term>Clinical trials</term>
<term>Clinician</term>
<term>Cohort</term>
<term>Consecutive patients</term>
<term>Control group</term>
<term>Cork university hospital</term>
<term>Cowpox</term>
<term>Cowpox infection</term>
<term>Current practice</term>
<term>Cutaneous</term>
<term>Cutaneous disease</term>
<term>Cutaneous features</term>
<term>Cutaneous manifestations</term>
<term>Cutaneous melanoma</term>
<term>Cutaneous symptoms</term>
<term>Database</term>
<term>Dermal</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatological</term>
<term>Dermatological manifestations</term>
<term>Dermatologist</term>
<term>Dermatologists british journal</term>
<term>Dermatology</term>
<term>Dermatology centre</term>
<term>Dermatology department</term>
<term>Dermatology transplant clinic</term>
<term>Dermatomyositis</term>
<term>Diphencyprone</term>
<term>Distress syndrome</term>
<term>Dos</term>
<term>Ectropion</term>
<term>Eczema</term>
<term>Edinburgh</term>
<term>Effective treatment</term>
<term>Epidermolysis</term>
<term>Epidermolysis bullosa</term>
<term>Erythema</term>
<term>Erythema migrans</term>
<term>Erythematosus</term>
<term>Erythrodermic psoriasis</term>
<term>Ester</term>
<term>Excision</term>
<term>Facial</term>
<term>Family members</term>
<term>Female patients</term>
<term>Foreign travel</term>
<term>Foundation trust</term>
<term>Fumaric</term>
<term>Fumaric acid esters</term>
<term>Gangrenosum</term>
<term>General population</term>
<term>General practitioner</term>
<term>Generalized vitiligo</term>
<term>Glucocorticoid</term>
<term>Graft</term>
<term>Guideline</term>
<term>Gvhd</term>
<term>Hair kinking</term>
<term>Hair loss</term>
<term>Half days</term>
<term>Healthcare</term>
<term>Healthcare professionals</term>
<term>Healthcare workers</term>
<term>High rate</term>
<term>Histiocytosis</term>
<term>Histology</term>
<term>Hydroxychloroquine</term>
<term>Imiquimod</term>
<term>Immunosuppressed</term>
<term>Immunosuppressed patients</term>
<term>Intravenous</term>
<term>Intravenous immunoglobulin</term>
<term>Isotretinoin</term>
<term>Juvenile dermatomyositis</term>
<term>Keloid</term>
<term>Kinking</term>
<term>Langerhans</term>
<term>Langerhans cell histiocytosis</term>
<term>Large teaching hospital</term>
<term>Lasik</term>
<term>Lesion</term>
<term>Lipid</term>
<term>Livedoid vasculopathy</term>
<term>Local toxicity</term>
<term>Localized</term>
<term>Longitudinal placement</term>
<term>Lower legs</term>
<term>Lupus</term>
<term>Lyme disease</term>
<term>Lymphoma</term>
<term>Male patients</term>
<term>Malignancy</term>
<term>Malignant</term>
<term>Malignant melanoma</term>
<term>Many patients</term>
<term>Media coverage</term>
<term>Median</term>
<term>Median number</term>
<term>Medical education</term>
<term>Medical history</term>
<term>Medication</term>
<term>Melanocyte</term>
<term>Melanoma</term>
<term>Methotrexate</term>
<term>Mofetil</term>
<term>Molecular medicine</term>
<term>Mtxpg3 concentration</term>
<term>Multiple lesions</term>
<term>Mutation</term>
<term>Mycophenolate</term>
<term>Mycophenolate mofetil</term>
<term>Mycosis fungoides</term>
<term>Myeloid</term>
<term>Myeloid sarcoma</term>
<term>Ndings</term>
<term>Neuropathic pruritus</term>
<term>Nodule</term>
<term>Northern ireland</term>
<term>Norwich</term>
<term>Novel approach</term>
<term>Oilatum</term>
<term>Ongoing</term>
<term>Oral prednisolone</term>
<term>Outpatient</term>
<term>Paediatric</term>
<term>Papule</term>
<term>Pasi</term>
<term>Pathogenesis</term>
<term>Pcos</term>
<term>Pharmacological treatment</term>
<term>Phenotype</term>
<term>Phototherapy</term>
<term>Placebo</term>
<term>Plaque</term>
<term>Poster</term>
<term>Potential risk</term>
<term>Prednisolone</term>
<term>Previous studies</term>
<term>Primary care</term>
<term>Programme</term>
<term>Progressive kinking</term>
<term>Prospective study</term>
<term>Pruritus</term>
<term>Psoriasis</term>
<term>Psoriasis area</term>
<term>Public awareness</term>
<term>Punch biopsy</term>
<term>Pyoderma</term>
<term>Pyoderma gangrenosum</term>
<term>Radiotherapy</term>
<term>Randomized</term>
<term>Range years</term>
<term>Rash</term>
<term>Recurrence</term>
<term>Referral</term>
<term>Regimen</term>
<term>Regrowth</term>
<term>Renal</term>
<term>Renal failure</term>
<term>Renal transplant</term>
<term>Renal transplant patients</term>
<term>Renal transplantation</term>
<term>Respiratory failure</term>
<term>Responder</term>
<term>Response rate</term>
<term>Response rates</term>
<term>Retreatment</term>
<term>Retrospective</term>
<term>Retrospective study</term>
<term>Rituximab</term>
<term>Roche</term>
<term>Roche brand</term>
<term>Roche group</term>
<term>Rosacea</term>
<term>Royal college</term>
<term>Salford</term>
<term>Sarcoma</term>
<term>Scarring</term>
<term>Seasonal variation</term>
<term>Sebum</term>
<term>Sebutape</term>
<term>Secondary care</term>
<term>Sepsis</term>
<term>Serious infections</term>
<term>Several months</term>
<term>Several years</term>
<term>Severe acne</term>
<term>Severe psoriasis</term>
<term>Severity index</term>
<term>Skin biopsy</term>
<term>Skin cancer</term>
<term>Skin cancer awareness</term>
<term>Skin disease</term>
<term>Skin graft</term>
<term>Skin infection</term>
<term>Skin lesions</term>
<term>Socs3</term>
<term>Socs3 gene expression</term>
<term>Squamous cell carcinoma</term>
<term>Stable vitiligo lesions</term>
<term>Steroid</term>
<term>Suppl</term>
<term>Surgical</term>
<term>Surgical debridement</term>
<term>Surgical excision</term>
<term>Surgical procedures</term>
<term>Sweet syndrome</term>
<term>Syndrome</term>
<term>Syphilis</term>
<term>Systemic</term>
<term>Systemic lupus erythematosus</term>
<term>Systemic symptoms</term>
<term>Systemic therapy</term>
<term>Teledermoscopy</term>
<term>Teledermoscopy model</term>
<term>Testosterone</term>
<term>Thalidomide</term>
<term>Therapeutic options</term>
<term>Topical</term>
<term>Topical imiquimod</term>
<term>Topical testosterone</term>
<term>Total cholesterol</term>
<term>Trainee</term>
<term>Transplant</term>
<term>Transplant patients</term>
<term>Transplantation</term>
<term>Tumour</term>
<term>Tumour necrosis factor</term>
<term>Tunga penetrans</term>
<term>Ulceration</term>
<term>University hospital</term>
<term>Upper arms</term>
<term>Vasculitis</term>
<term>Vasculopathy</term>
<term>Vitiligo</term>
<term>White woman</term>
<term>Whole blood</term>
<term>Young adults</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001577 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001577 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:715C0A559B50A8FE9E76AFA8ACA0294D0F6F6707
   |texte=   Bristol Cup Posters
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021